Precirix

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Aktis Oncology

This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

Akiram Therapeutics

This biotech company develops targeted radiopharmaceuticals and radioimmunotherapies for patients with solid tumours and metastatic cancers.

Cereius

This company develops targeted radiopharmaceuticals and radiodiagnostics for cancer patients, focusing on the treatment of solid tumour brain metastases.

Anaveon

The company develops precision biologics and engineered antibodies to treat patients with cancer and autoimmune diseases.